Vivasure Medical
Parkmore Business Park West
Galway ,
Ireland
Phone: +353 91 395 440
Fax: +353 91 395 399
Visit Website
Product Categories:
Cath Lab, Hemostasis Management, Vascular Closure Devices

Related Content

Investigational technology designed for patients undergoing emerging large bore percutaneous catheter-based venous interventional procedures
News | Vascular Closure Devices
Vivasure Medical Announces First Large Hole Venous Patient Treated with PerQseal Elite Vascular Closure System

April 16, 2024 — Vivasure Medical, a company pioneering novel fully absorbable technology for percutaneous vessel ...

Home April 16, 2024
arrow
Vivasure Medical, a company pioneering novel fully absorbable technology for percutaneous vessel closure, today announced that the first patient was treated in a U.S. early feasibility study evaluating PerQseal+, the next generation of the company’s PerQseal device.
News | Structural Heart
Vivasure Medical Announces First Patient Treated in U.S. Early Feasibility Study Evaluating PerQseal+
March 31, 2022 – Vivasure Medical, a company pioneering novel fully absorbable technology for percutaneous vessel ...
Home March 31, 2022
arrow
Leveraging Vivasure Medical’s PerQseal vascular closure device technology, PerQseal Blue consists of an intravascular patch designed to seal the vessel from the inside, returning the vein to its natural state after it dissolves over time, so no foreign bodies are left behind.
News | Vascular Closure Devices
Vivasure Medical is Developing a Sutureless Venous Closure Device for Transcatheter Valve Procedures

July 15, 2021 — Vivasure Medical announced its development program for PerQseal Blue, a sutureless and fully ...

Home July 15, 2021
arrow
PerQseal Large Bore Closure Device Launches in Europe
News | Vascular Closure Devices
PerQseal Large Bore Closure Device Launches in Europe

November 21, 2018 – Vivasure Medical Ltd. recently announced the European launch of the PerQseal closure device for ...

Home November 21, 2018
arrow
Vivasure Enrolls First Patient in Frontier IV Clinical Trial
News | Vascular Closure Devices
Vivasure Enrolls First Patient in Frontier IV Clinical Trial

December 29, 2017 — Vivasure Medical announced in October the successful enrollment of the first patient in the Frontier ...

Home December 29, 2017
arrow
Vivasure Medical, Closure Device, Series C financing
News | Vascular Closure Devices
Vivasure Medical Announces $18.3M in Series C Financing

September 12, 2016 — Vivasure Medical announced last week that the company has completed a Series C financing of €16.2M ...

Home September 12, 2016
arrow
Vivasure Medical, PerQSeal, vascular closure device, CE Mark
News | Vascular Closure Devices
Vivasure Gains European Approval for Bioabsorbable Percutaneous Closure Device for Large-Bore Transcatheter Procedures

January 18, 2016 — Vivasure Medical announced Conformité Européenne (CE) Mark approval of the world’s first fully ...

Home January 18, 2016
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now